Zhe Liu
Research Subjects
Zhe Liu has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Jianzhong Du
East China University of Science and Technology
1 shared publication - Yao Xu
Department of Polymeric Materials School of Materials Science and Engineering Tongji University Shanghai China
1 shared publication - Yong Hu
Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, Shanghai, China
1 shared publication - Yu Fan
Department of Polymeric Materials, School of Materials Science and Engineering, Tongji University, Shanghai 201804, People's Republic of China
1 shared publication - Yuyan Qian
Department of Polymeric Materials, School of Materials Science and Engineering
1 shared publication - Zhen Fan
Tongji University 4800 Caoan Road
1 shared publication
Latest Publications
- 26 May 2025
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 25 (22) , 9139-9148
Circularization of Aptamer Nanomedicine Improves Nuclease Resistance, Targeted Recognition, and Transdermal Effect for Topical Psoriasis Therapy
Inhibiting excessive hyperproliferation and inflammatory responses of keratinocytes are two primary tasks against psoriasis, which, however, have not been well integrated by the current available nanomedicines. Herein, we develop a nucleic acid nanomedicine through coassembly of circular aptamers and gold nanoclusters via electrostatic interactions for psoriasis therapy. After topical application, this nanomedicine bearing vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF-α) aptamers crosses the stratum corneum and enters the deep layers of psoriatic site, from which it specifically inhibits VEGF-mediated keratinocyte proliferation and TNF-α-mediated inflammatory responses simultaneously. More importantly, the circular aptamers further promote the nuclease resistance, targeted recognition, and transdermal effect of the nanomedicine, as compared to their linear counterparts. These improved synergistic actions effectively prevent and cure psoriasis of mice induced by imiquimod. It is anticipated that this study provides a general strategy for targeted regulation of intricate pathological microenvironments beyond psoriasis.
- 26 May 2025
- Published by American Chemical Society (ACS) in Nano Letters
- Vol. 25 (22) , 9139-9148
Circularization of Aptamer Nanomedicine Improves Nuclease Resistance, Targeted Recognition, and Transdermal Effect for Topical Psoriasis Therapy
Inhibiting excessive hyperproliferation and inflammatory responses of keratinocytes are two primary tasks against psoriasis, which, however, have not been well integrated by the current available nanomedicines. Herein, we develop a nucleic acid nanomedicine through coassembly of circular aptamers and gold nanoclusters via electrostatic interactions for psoriasis therapy. After topical application, this nanomedicine bearing vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF-α) aptamers crosses the stratum corneum and enters the deep layers of psoriatic site, from which it specifically inhibits VEGF-mediated keratinocyte proliferation and TNF-α-mediated inflammatory responses simultaneously. More importantly, the circular aptamers further promote the nuclease resistance, targeted recognition, and transdermal effect of the nanomedicine, as compared to their linear counterparts. These improved synergistic actions effectively prevent and cure psoriasis of mice induced by imiquimod. It is anticipated that this study provides a general strategy for targeted regulation of intricate pathological microenvironments beyond psoriasis.